Metagenomi (MGX) Institutional Ownership

During the previous two years, 51 institutional investors and hedge funds held shares of Metagenomi. The most heavily invested institutionals were Farallon Capital Management LLC ($14.17M), Hhlr Advisors LTD. ($8.21M), Novo Holdings A S ($7.34M), Artal Group S.A. ($3.17M), RA Capital Management L.P. ($2.83M), PFM Health Sciences LP ($2.24M), and Geode Capital Management LLC ($2.12M).Learn more on MGX's institutional investors.

Of the 41 institutional investors that purchased Metagenomi stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($1.74M), Farallon Capital Management LLC ($1.34M), Hhlr Advisors LTD. ($777.77K), Geode Capital Management LLC ($423.19K), Norges Bank ($360.20K), Peapod Lane Capital LLC ($351.21K), and Artal Group S.A. ($300K).

Institutional investors have bought a total of 7,009,055 shares in the last 24 months. This purchase volume represents approximately $55.98M in transactions.

Of the 14 institutional investors that sold Metagenomi stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Citadel Advisors LLC ($654.76K), Millennium Management LLC ($403.47K), Point72 Asset Management L.P. ($272.10K), PFM Health Sciences LP ($233K), RA Capital Management L.P. ($172.51K), Marshall Wace LLP ($135.11K), and Jacobs Levy Equity Management Inc. ($70.44K).

Institutional investors have sold a total of 2,114,253 shares in the last 24 months. This volume of shares sold represents approximately $7.16M in transactions.